US trade talks at crucial stage; India sticks to agriculture, dairy stand
India and the US are in crucial trade talks. New Delhi is firm on its stance regarding market access in agriculture. This includes GM crops and dairy. India hopes for a deal before July 9. After July 9, reciprocal tariffs from the US will take effect. India will not compromise the interests of its farmers.
Tired of too many ads?
Remove Ads
Tired of too many ads?
Remove Ads
The India-US trade pact talks are at a crucial stage with New Delhi sticking to the red line on the issue of market access in agriculture, genetically modified (GM) crops, and dairy, people privy to the development said.However, efforts are on to stitch the trade deal before July 9, when 26% reciprocal tariffs by the Donald Trump administration will come into effect, they added. "We are hopeful of a deal...But there would be no compromise on the interests of Indian farmers," one the persons told ET."India's stance in these areas is very clear," said another person. "There are red lines that will not be crossed".India's trade negotiators extended their stay in Washington, beyond the scheduled two-day visit ending June 27, as talks with the US government stretched on."The talks are at a critical juncture," said a third person, adding that the deal could also be in multiple phases with certain details following later.Trump had on April 2 announced a reciprocal tariff of 26% on goods imports from India as part of the administration's trade levies on many countries. The tariffs were paused for 90 days until July 9. However, the baseline tariff of 10% will stay in force even if the reciprocal tariffs are lifted after a trade deal.The US wants to be able to sell GM crops and cattle feed to India, a sensitive issue for New Delhi. These segments are difficult and challenging areas for India as local farmers are mostly into sustenance farming and have small land holdings. Washington, on its part, is not willing to lower tariffs below the baseline 10%. "There are certain non-negotiables for India which it has told the US," an official said.The commerce and industry ministry has already informed domestic exporters and industry that talks are on to finalise the first phase and that there would be more phases.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
6 minutes ago
- Business Standard
Apollo Hospital rallies after board OKs demerger of digital & pharmacy units
Apollo Hospital Enterprise (AHEL) added 3.25% to Rs 7,477.95 after the company's board approved to spin-off its omnichannel pharmacy and digital health businesses through scheme of arrangement. The board of AHEL and its subsidiary, Apollo HealthCo granted in-principle approval for the demerger of Omnichannel Pharma and Digital Health business. The proposed structure enables direct access of omni-channel pharmacy and digital health business to the shareholders of AHEL. For every 100 shares of AHEL, the shareholders of AHEL will receive 195.2 shares of the new company, Apollo Healthtech enabling their direct participation in the value unlock. The proposed transaction will result in the creation of the largest, integrated omni channel healthcare eco-system with a FY25 revenue of approximately Rs 16,300 crore ($ 1.9 billion) in FY25. The Apollo Healthtech is expected to achieve a revenue run rate of Rs 25,000 crore ($2.9 billion) by FY27. Upon the effectiveness of the Scheme, Apollo Healthtech will become an Indian owned and controlled company (IOCC) and it will apply for listing on the stock exchanges. The listing is expected within 18 to 21 months. AHEL will retain 15% stake in the Apollo Healthtech to ensure an integrated, seamless, and comprehensive healthcare offering across the patient lifecycle. Upon becoming an IOCC, the Apollo Healthtech also proposes to consolidate the front-end pharmacy business by acquiring the remaining 74.5% stake in Apollo Medicals (AMPL), which owns 100% of APL. Dr Prathap C Reddy, chairman, Apollo Hospitals Group, said "Today's developments mark the beginning of the next chapter of Apollo Hospitals' relentless mission to bring healthcare of world-class standards within the reach of every individual. The omnichannel pharmacy business and integrated digital healthcare ecosystem will be a unique model to enable access to high-quality healthcare for millions of Indians. What Apollo Hospitals achieved for the creation of the private healthcare industry in India, this new entity will create for the digitally forward generation of tomorrow. We have the opportunity to make a positive difference to their lives and partner in their wellness pursuits. I wish both the teams all the best as they enter uncharted territory with infinite potential." Suneeta Reddy, managing director, Apollo Hospitals Enterprise said, "Apollo has always focused on growth, reach, and scale. We have carefully built our formats-of-care around the consumer at the centre. This comprehensive integrated network, overlaid with a strong digital layer, will allow us to create an impact of magnitude greater than could be achieved with a single format of care. AHEL will continue its focus on outstanding healthcare delivery, while the New Entity will accelerate its efforts on deepening customer engagement and penetration, with clear capital allocation outlays, growth plans and management teams driving both. Together, we will generate unparalleled value for the consumer, while making sure that all synergies and network effects stay intact, rooted in the Apollo ethos of quality and trust." Shobana Kamineni, executive chairperson, Apollo HealthCo said, "The New Entity, once integrated, will be a truly customer-focused healthcare leader, with capabilities across the value chain. Delivering medicines seamlessly from more than 7,000 physical stores, online delivery platform serving over 19,000 pincodes, with Keimed ensuring supply chain integrity, our aspiration is that we will serve over 100 million Indians with trusted quality and availability. With each business expected to record healthy rates of growth, we will continue to be the leader in this sector. Apollo Hospitals Enterprise has established a strong presence across the healthcare ecosystem, encompassing hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. The company reported 53.5% jump in consolidated net profit to Rs 389.60 crore on 13.1% increase in revenue from operations to Rs 5,592.20 crore in Q4 FY25 over Q4 FY24.
Hindustan Times
10 minutes ago
- Hindustan Times
India and Pakistan exchange lists of prisoners
India and Pakistan on Tuesday exchanged lists of prisoners in each other's custody, with New Delhi asking Islamabad to expedite the release of 159 Indian nationals who have completed their prison terms and to provide consular access to 26 more prisoners. Border Security Force personnel stand guard near the last gate of the India-Pakistan International border at Suchetgarh octroi post on the outskirts of Jammu. (PTI) The two countries exchange lists of prisoners and fishermen twice a year, on January 1 and July 1, under provisions of the 2008 Agreement on Consular Access. This is among a limited number of bilateral mechanisms and arrangements that remain operational between the two sides, another being the exchange on January 1 of lists of nuclear installations that cannot be attacked during hostilities. India shared the names of 382 civilian prisoners and 81 fishermen in its custody who are Pakistani or believed to be Pakistani, the external affairs ministry said. The Pakistani side provided a list of 53 civilian prisoners and 193 fishermen in its custody who are Indian or believed to be Indian. The lists were simultaneously exchanged through diplomatic channels in New Delhi and Islamabad, the ministry said. 'The government of India has called for early release and repatriation of civilian prisoners, fishermen along with their boats, and missing Indian defence personnel from Pakistan's custody,' the ministry said. Pakistan was asked to expedite the release and repatriation of 159 Indian fishermen and civilian prisoners who had completed their sentences. Pakistan was also asked to provide immediate consular access to 26 civilian prisoners and fishermen in its custody who are believed to be Indian and have not been provided such access so far, the ministry said. India urged Pakistan to expedite the process of verifying the nationality of 80 civilian prisoners and fishermen in India's custody who are believed to be Pakistani, and whose repatriation has been held up for lack of confirmation of their nationality by Islamabad. 'Pakistan has been requested to ensure the safety, security and welfare of all Indian and believed-to-be-Indian civilian prisoners and fishermen, pending their release and repatriation to India,' it said. The external affairs ministry said efforts by the Indian government have resulted in 2,661 Indian fishermen and 71 civilian prisoners being repatriated from Pakistan since 2014. This includes 500 fishermen and 13 civilian prisoners repatriated since 2023. 'India remains committed to addressing, on priority, all humanitarian matters, including those pertaining to prisoners and fishermen in each other's country. In this context,' the ministry said. India and Pakistan have not had any sustained talks since New Delhi called off the composite dialogue in the aftermath of the 2008 Mumbai attacks, which were carried out by a 10-member team of Pakistan-based Lashkar-e-Taiba (LeT). Following the Pahalgam terror attack in April, India announced a raft of punitive diplomatic and economic measures against Pakistan, including the suspension of the Indus Waters Treaty of 1960.
India Today
13 minutes ago
- India Today
Suzuki Motorcycle India records 8% sales growth in June 2025, 95,244 units sold
Suzuki Motorcycle India (SMIPL), the Indian subsidiary of Japan's Suzuki Motor Corporation, has reported total sales of 95,244 units in June 2025, marking an 8% year-on-year growth compared to 88,287 units sold in June company's domestic sales stood at 73,934 units, up 4% from 71,086 units in the same month last year, reflecting sustained demand across urban and semi-urban markets. On the international front, exports saw a robust 24% jump, with 21,310 units shipped compared to 17,201 units in June 2024, highlighting Suzuki's growing global on the company's performance, Deepak Mutreja, Vice President – Sales & Marketing, Suzuki Motorcycle India Pvt. Ltd., said, "We remain optimistic as our growth continues across both domestic and international markets. Our continued focus on delivering superior riding experience and customer centric approach is driving this performance. We will continue to offer greater value to our customers as we strengthen our presence across markets and gear up for the months ahead." Adding to its momentum, Suzuki Motorcycle India expanded its product portfolio in June by launching OBD-2B compliant models of the Suzuki GSX-8R and introducing the V-Strom 800DE in three new colour options, catering to evolving customer preferences and regulatory company's consistent growth reflects its focus on premium offerings, expanding dealership reach, and alignment with evolving emission to Auto Today Magazine- Ends
